Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ramsedhom
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ramsedhom
-
Ramy Sedhom proslijedio/la je Tweet
Great new review of
#palliativecare in#hematology, from@Areejmd and@StephanieLeeMD in@ASCO_pubs JCO. Check it out: https://ascopubs.org/doi/full/10.1200/JCO.18.02386 …#hpm#hapc#pallonc#pallheme#hpmblood@ASH_hematologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
"The value we provide is not hanging a bag of chemo—but that is what the “buy and bill” model says our value is." Thanks to
@ASCOPost for allowing me to share thoughts on our chemo reimbursement model!@peterbachmd@contirena1@drdgoldstein https://www.ascopost.com/news/february-2020/comparing-prescribing-habits-in-academic-and-nonacademic-oncology-settings/ … 1/Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
When Is a Suboptimal Approach to Cancer Screening Better Than None? https://journalofethics.ama-assn.org/article/when-suboptimal-approach-cancer-screening-better-none/2020-02 … via
@ramsedhom &@oncology_bg@felly500@SteveLaitner@PHE_Screening@janewilcockHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
I'm often asked by patients, family members, referring physicians, or clinical trial sponors: "So how do you guys pick which clinical trials to do, anyway?" There are hundreds of trials in hematologic malignancy ongoing... how to choose? Here are some thoughts. Image:
@NIHpic.twitter.com/5JQ9u6oAKw
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Brilliant & true! Sadly, this story extends to the medical student, resident, fellow, young faculty whose passions are offset by arbitrary metrics we set to define success
@guptaarjun90 Stopping the Med School 'Arms Race' https://www.medscape.com/viewarticle/924457?src=soc_tw_share … via@medscape@VPrasadMDMPHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
Billing Quality Is Medical Quality. Can create accountability for hospitals. -
@simoncmathews1@MartyMakary in@JAMA_current
Itemized bill, plain language
Real time price transparency
Speak to a billing rep prn
Suing patients
Surprise billshttps://ja.ma/2UoKOjJ Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great review by
@guptaarjun90 and@TimothyJBrownMD on management of oral mucositishttps://twitter.com/guptaarjun90/status/1224726086316986368 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
You can say that again. "There's no algorithm for [genuine] empathy." Period. Outstanding. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2019.00571 …
@Health_Affairs by Hannah Wild@StanfordMed med student https://cap.stanford.edu/profiles/frdActionServlet?choiceId=printerprofile&profileversion=full&profileId=150241 …#MedEd#medhumchatpic.twitter.com/F4adiObPJo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
Feb
@Health_Affairs is out! We did a formal return on investment (ROI) analysis of the IMPaCT community health worker program using randomized controlled trial evidence. Each dollar invested by Medicaid returns $2.47, annually. http://bit.ly/2QNt4v4@threadreaderapp unrollpic.twitter.com/k9UVldYuwJ
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
We made in Medscape! Thanks so much to all those who contributed their thoughts.
@VincentRK@ramsedhom@DrewBruggeman@Alexmenter 'How Long Do I Have?' New Online Tool for Patients With Cancer https://www.medscape.com/viewarticle/924688?src=soc_tw_share … via@medscapePrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Reflection: was 17 years from Andy Reid’s first job as an assistant for BYU to his 1st NFL head coaching job for the Eagles Then another 21 years to his first SuperBowl win Achieving your dream takes time Enjoy the journey
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
thanks to
@JournalofEthics for publishing our commentary, alongside many other great piecesPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I worry that a similar ethical paradox exists in the US For most diseases, equal Rx yields equal outcomes among equal patients. Yet, we know this does NOT happen & there is not enough concern about this Disparities always increase when there is scientific progress in medicine
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We conclude that screening in LICs without good follow-up care across the cancer continuum makes little clinical or ethical sense; resources are better spent on education related to tobacco cessation, alcohol control, diet and lifestyle promotion
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
screening must be acceptable, equitable, accessible, sustainable and economically efficient (one can see here how the aims for screening are different in LIC & HICs) for screening programs to be effective & appropriate -- affordable, high quality treatment must be available
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
quick side note that many QI projects (here in the US) have a similar dilemma (SAD!) I've led a project with the goal of ↑retinopathy screening for diabetics in a FQHC & quickly realized we had no specialist to send the patients to! EQUITY is a global problem!
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
resources for cancer are limited in low-income relative to HIC and thus mortality rates are greater screening in LIC has a paradoxical dilemma: -no screening = ↑ odds of adv dz (harder to Rx) -screening prog = what do u do w/+ tests if no avail Rx (+anxiety/financial tox)
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thx
@oncology_bg for the invitation & mentorship on this piece. We discuss the ethics of screening a woman for breast cancer in a remote, resource-laden region, without access to treatment (this is key) A few broad lessons learned & themes that may apply to western medicinehttps://twitter.com/oncology_bg/status/1223632941550571531 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
Great thread highlighting new work from
@oncology_bg and his mentees@ADesaiMD and@ramsedhomhttps://twitter.com/oncology_bg/status/1223961364881866752 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramy Sedhom proslijedio/la je Tweet
I’m super excited about the 3 papers we published in last two days, because in all these three papers I had the opportunity to work with a younger colleague who is going to be a KOL in oncology. 1. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30013-4/fulltext … 2. https://journalofethics.ama-assn.org/article/when-suboptimal-approach-cancer-screening-better-none/2020-02 … 3. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30023-7/fulltext …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.